Analyst consensus rating

ADARx Pharmaceuticals Analyst Rating: Strong Buy

Direct answer

ADARx Pharmaceuticals's consensus rating is Strong Buy.

4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $33.75.
Forecast evidence checked November 19, 2026.

Get free ADARx Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$13.57
Average price target
$33.75
High price target
$36.00
Low price target
$32.00
Low target gap
+135.9%
Target upside
+148.8%
High target gap
+165.4%
Target range width
29.5%
Consensus rating
Strong Buy
Analysts
4
Evidence date
November 19, 2026
Valid through
November 26, 2026

Read the frequently asked questions.

What is the analyst consensus rating for ADARx Pharmaceuticals?

ADARx Pharmaceuticals has a verified Strong Buy consensus. The same dataset has an average price target of $33.75.

How far are ADARx Pharmaceuticals's low and high targets from the recorded price?

The low target implies +135.9%, while the high target implies +165.4%.

How many analysts are included in ADARx Pharmaceuticals's consensus?

The verified consensus includes 4 analysts.

How is ADARx Pharmaceuticals's target upside or downside calculated?

The average target of $33.75 is divided by the recorded price of $13.57, then one is subtracted to produce +148.8%. This does not guarantee a future return.

When was ADARx Pharmaceuticals's analyst forecast verified?

The data was verified on 2026-11-19. The dataset is valid through 2026-11-26.